Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes
Latest Top (15) News
Approaches To Therapy Escalation In T2D Condition: Type2 Diabetes Interventions: Drug: DPP-4 inhibitor; Drug: SGLT2 inhibitor; Drug: SGLT2 inhibitor and DPP-4 inhibitor Sponsors: LMC Diabetes & Endocrinology Ltd.; Merck Sharp & Dohme Corp.; Syreon Corporation Not yet recruiting
Wed, 23 Jan 2019 12:00:00 EST Comparative Effectiveness of Family vs. Individually Focused Diabetes Education and Support Conditions: Diabetes Mellitus; High Blood Pressure; High Blood Sugar; Hypertension Interventions: Behavioral: FAM ACT; Behavioral: I-DSME+CM Sponsors: University of Pittsburgh; The Community Health and Social Services Center, Inc.; University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting
Wed, 23 Jan 2019 12:00:00 EST Vitamin D Treatment of Diabetic Patients With Foot Ulcers Conditions: Diabetic Foot Ulcers; Vitamin D Deficiency Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: Placebo Sponsor: Zealand University Hospital Completed
Wed, 23 Jan 2019 12:00:00 EST A Coordinated Parent/Child Dyad Weight Loss Intervention: Dyad Plus Conditions: Weight Loss; Pediatric Obesity Interventions: Behavioral: Standard Care; Behavioral: By Design; Behavioral: Dyad Plus Sponsors: Wake Forest University Health Sciences; National Institutes of Health (NIH) Not yet recruiting
Mon, 21 Jan 2019 12:00:00 EST China Diabetes Registry by Metabolic Management Center Conditions: Type 2 Diabetes Mellitus; Type1 Diabetes Mellitus; Monogenetic Diabetes; Pancreatogenic Diabetes; Drug-Induced Diabetes Mellitus; Other Forms of Diabetes Mellitus Intervention: Other: Standard diabetes management model in each MMC center Sponsor: Guang Ning Recruiting
Mon, 21 Jan 2019 12:00:00 EST FES Cycling and Nutritional Counseling for Battling Obesity After SCI Condition: Spinal Cord Injuries Interventions: Combination Product: HIIT-FES Cycling combined with Nutritional Counseling; Other: Nutritional Counseling Only Sponsors: William Carey University; University of Southern Mississippi; University of Mississippi Medical Center Recruiting
Mon, 21 Jan 2019 12:00:00 EST Feasibility and Safety of Walking Football in Patients With Type 2 Diabetes Condition: Diabetes Mellitus, Type 2 Intervention: Behavioral: Walking football exercise program Sponsors: Universidade do Porto; Federação Portuguesa de Futebol, Portugal; Administração Regional de Saúde do Norte, Portugal; Fédération Internationale de Football Association Active, not recruiting
Mon, 21 Jan 2019 12:00:00 EST Fecal Incontinence Treatment (FIT) Study Conditions: Fecal Incontinence; Bowel Incontinence Interventions: Behavioral: Biofeedback; Procedure: Sacral Nerve Stimulation; Device: Injection Sponsors: University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Mayo Clinic; Colon and Rectal Surgery Associates, Ltd.; Augusta University; RTI International Not yet recruiting
Mon, 21 Jan 2019 12:00:00 EST Janagliflozin Treat T2DM Monotherapy Condition: Diabetes Type 2 Interventions: Drug: Janagliflozin 25mg; Drug: Janagliflozin 50mg; Drug: Placebo/Janagliflozin Sponsor: Sihuan Pharmaceutical Holdings Group Ltd. Not yet recruiting
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Fri, 21 Dec 2018 10:37:00 -0500 FDA approves first treatment for rare blood disease The FDA approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients, two years of age and older.
